Who are we?
A team dedicated to helping people with diabetes achieve better health outcomes and have a better quality of life.
Why Quin?
We want to create technology to redefine the diabetes management experience through a more holistic approach. Technology is everywhere in diabetes, yet people still experience a 92% failure to achieve targets and have an increased exposure to serious mental health issues. We want to change that.
What does Quin stand for?
Quin is a portmanteau for Quantifying Intuition. Something people who take insulin do several times a day, every day.
Our mission
We’re using science, engineering and design to help people who take insulin make the best possible decisions.
Our vision
We leverage human experience to develop new technologies and knowledge and give power to people living with chronic conditions, starting with diabetes.
Our values
Be Excellent; Find Truth; Show Love. We try to incorporate these in everyday actions both inside and outside of Quin .
Our approach
We believe diabetes is an umbrella term for chronic high blood glucose. Our technology is built on the premise that your past is the best indicator of your future.
Milestones
Our biggest achievements to date
October 2020
Quin is officially live in the Apple AppStore
June 2020
Our app is available for pre-order in the App Store
May 2020
Quin became ISO 13485 certified
March 2020
Quin raised £690,000 in a crowdfunding campaign
October 2019
Quin won the Diabetes Center Berne Startup Challenge
October 2019
We were selected for the Apple Entrepreneur Camp
July 2019
100+ beta users joined our research programme
May 2019
Quin raised £645k in angel funding
December 2018
We were selected for the KQ Labs Accelerator
November 2018
Quin raised £540k in angel funding
November 2018
We were selected to win an £323k Innovate UK Grant
February 2018
Quin wins Advanced Technologies & Treatments for Diabetes startup grant
September 2017
We raised £398k in angel funding
May 2017
Quin achieves Class I CE Mark
2014
Quin is incorporated under Ayuda Heuristics
Team
We’ve got a strong, proven team dedicated to improving the day to day lives of people living with diabetes.
Cyndi Williams
CEO
Chris Socha
Senior Software Engineer
Melissa Marshall
Senior Software Engineer
Vanessa Bolosier
Head of Marketing
Arash Pessian
Senior Software Engineer
Duncan Mortimer
Machine Learning Engineer
Michaela Regan
Product Marketer
Liam Mitchell
Product Designer
Esme Shanley
Head of Operations
Siobhan Wynter
Product Designer
Barry Rogers
VP of Product
Justine Yuen
Creative Content Producer
Our Boards
Our board members each have vast experience and a strong passion for making life with diabetes easier through technology.
Executive Board
The members of our executive board are Johanna Waterous a partner at McKinsey for 23 years that has lived with type 1 diabetes for decades, Markku Koppinen, former COO at Auto Trader and a senior executive at Nokia, and John Lister, former GM of Dexcom EMEA who took them through an IPO and from zero to $1B in revenues.
Clinical Advisory Board
On our Clinical Advisory Board we have three highly respected diabetologists, including Professor Jeremy Turner and Dr. Sankalpa Neupane from Norfolk and Norwich University Hospitals, and Dr. Nicola Neary from St. George’s University Hospitals.
© 2021 Quin Technology LTD. All rights reserved. Registered No. 09206022
